Application 090641
- Type
- ANDA
- Sponsor
- MYLAN ASI
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SUMATRIPTAN SUCCINATE | SUMATRIPTAN SUCCINATE | INJECTABLE;SUBCUTANEOUS | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25021-703 | sumatriptan | sumatriptan | Sagent Pharmaceuticals | ANDA | Current |
| 50090-2053 | sumatriptan | sumatriptan | A-S Medication Solutions | ANDA | Current |
| 67457-880 | sumatriptan | sumatriptan | Mylan Institutional LLC | ANDA | Current |
| 67457-880 | sumatriptan | sumatriptan | Mylan Institutional LLC | ANDA | Current |
| 67457-880 | sumatriptan | sumatriptan | Mylan Institutional LLC | ANDA | Current |